Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
出版年份 2022 全文链接
标题
Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
作者
关键词
-
出版物
Frontiers in Neurology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-03-29
DOI
10.3389/fneur.2022.862369
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Aducanumab and the FDA — where are we now?
- (2021) Howard Fillit et al. Nature Reviews Neurology
- Monoclonal Antibodies as Neurological Therapeutics
- (2021) Panagiotis Gklinos et al. Pharmaceuticals
- Donanemab in Early Alzheimer’s Disease
- (2021) Mark A. Mintun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of Aducanumab for Alzheimer Disease
- (2021) G. Caleb Alexander et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
- (2021) Chad J. Swanson et al. Alzheimers Research & Therapy
- Aducanumab produced a clinically meaningful benefit in association with amyloid lowering
- (2021) Jeffrey Cummings et al. Alzheimers Research & Therapy
- Critical Appraisal of Amyloid Lowering Agents in AD
- (2021) Boris Decourt et al. Current Neurology and Neuroscience Reports
- Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent
- (2021) Winston Chiong et al. NEUROLOGY
- Six Recurrent Amyloid-Related Imaging Abnormality Episodes in a Patient Treated With Aducanumab
- (2021) Jacob N. Hall et al. JAMA Neurology
- Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
- (2021) Stephen Salloway et al. JAMA Neurology
- Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease
- (2020) Samantha Budd Haeberlein et al. Alzheimers & Dementia
- Alzheimer disease and aducanumab: adjusting our approach
- (2019) Dennis J. Selkoe Nature Reviews Neurology
- A resurrection of aducanumab for Alzheimer's disease
- (2019) Lon Schneider LANCET NEUROLOGY
- Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
- (2019) Steven M. Greenberg et al. Nature Reviews Neurology
- Anti-Amyloid-β Monoclonal Antibodies for Alzheimer’s Disease: Pitfalls and Promise
- (2018) Christopher H. van Dyck BIOLOGICAL PSYCHIATRY
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Efficacy and safety of anti-amyloid-β immunotherapy for Alzheimer's disease: a systematic review and network meta-analysis
- (2017) Jia-Jie Mo et al. Annals of Clinical and Translational Neurology
- Monitoring Blood-Brain Barrier Integrity Following Amyloid-β Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model
- (2016) Ines Blockx et al. JOURNAL OF ALZHEIMERS DISEASE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
- (2016) Veronika Logovinsky et al. Alzheimers Research & Therapy
- Aducanumab (BIIB037), an anti-amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer’s disease: Interim results of a randomized, double-blind, placebo-controlled, phase 1b study
- (2015) Jeff Sevigny et al. Alzheimers & Dementia
- MR Imaging Features of Amyloid-Related Imaging Abnormalities
- (2013) J. Barakos et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice
- (2012) Ronald B. DeMattos et al. NEURON
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease
- (2010) S Sakura Minami et al. Journal of Neuroinflammation
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started